1. Home
  2. STXS vs DHF Comparison

STXS vs DHF Comparison

Compare STXS & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • DHF
  • Stock Information
  • Founded
  • STXS 1990
  • DHF 1998
  • Country
  • STXS United States
  • DHF United States
  • Employees
  • STXS N/A
  • DHF N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DHF Finance Companies
  • Sector
  • STXS Health Care
  • DHF Finance
  • Exchange
  • STXS Nasdaq
  • DHF Nasdaq
  • Market Cap
  • STXS 275.9M
  • DHF 185.7M
  • IPO Year
  • STXS 2004
  • DHF N/A
  • Fundamental
  • Price
  • STXS $2.67
  • DHF $2.54
  • Analyst Decision
  • STXS Strong Buy
  • DHF
  • Analyst Count
  • STXS 1
  • DHF 0
  • Target Price
  • STXS $4.00
  • DHF N/A
  • AVG Volume (30 Days)
  • STXS 461.9K
  • DHF 451.1K
  • Earning Date
  • STXS 11-11-2025
  • DHF 01-01-0001
  • Dividend Yield
  • STXS N/A
  • DHF 7.65%
  • EPS Growth
  • STXS N/A
  • DHF N/A
  • EPS
  • STXS N/A
  • DHF N/A
  • Revenue
  • STXS $31,806,000.00
  • DHF N/A
  • Revenue This Year
  • STXS $30.98
  • DHF N/A
  • Revenue Next Year
  • STXS $49.86
  • DHF N/A
  • P/E Ratio
  • STXS N/A
  • DHF N/A
  • Revenue Growth
  • STXS 33.94
  • DHF N/A
  • 52 Week Low
  • STXS $1.54
  • DHF $2.06
  • 52 Week High
  • STXS $3.59
  • DHF $2.39
  • Technical
  • Relative Strength Index (RSI)
  • STXS 36.79
  • DHF 40.91
  • Support Level
  • STXS $2.68
  • DHF $2.56
  • Resistance Level
  • STXS $3.15
  • DHF $2.58
  • Average True Range (ATR)
  • STXS 0.12
  • DHF 0.02
  • MACD
  • STXS -0.05
  • DHF -0.00
  • Stochastic Oscillator
  • STXS 3.65
  • DHF 16.67

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About DHF BNY Mellon High Yield Strategies Fund

BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. The fund invests predominantly in fixed-income securities of below-investment-grade credit quality.

Share on Social Networks: